Brenda Goguen
About Brenda Goguen
Brenda Goguen is a Senior Director of New Product Planning and Corporate Strategy at Wave Life Sciences, where she has worked since 2021. She has extensive experience in the life sciences sector, blending scientific expertise with commercial acumen, and has held previous positions at Sanofi Genzyme and Clarion.
Current Role at Wave Life Sciences
Brenda Goguen serves as the Senior Director of New Product Planning & Corporate Strategy at Wave Life Sciences. She has held this position since 2021, contributing to the company's strategic direction and product development initiatives. Her role involves overseeing the planning and execution of new product strategies, ensuring alignment with corporate goals. Based in Cambridge, Massachusetts, she plays a key part in the organization’s efforts to advance innovative therapies in the life sciences sector.
Previous Experience at Sanofi Genzyme
Before joining Wave Life Sciences, Brenda Goguen worked at Sanofi Genzyme as the Director of New Product Planning from 2019 to 2021. During her two years in this role, she was responsible for leading product planning efforts and contributing to the strategic development of new therapies. Her experience at Sanofi Genzyme added to her expertise in the life sciences, particularly in managing the complexities of product development in a global pharmaceutical context.
Career at Clarion | A Life Sciences Consultancy
Brenda Goguen spent eight years at Clarion, a life sciences consultancy, where she held the position of Principal from 2011 to 2019. In this role, she leveraged her scientific and analytical skills to address various challenges faced by clients in the biotech and pharmaceutical industries. Her work involved guiding companies through the product development process, from preclinical stages to market launch, enhancing her understanding of the life sciences landscape.
Education and Expertise in Chemistry
Brenda Goguen holds a Ph.D. in Chemistry from the Massachusetts Institute of Technology, where she studied from 2005 to 2011. Prior to that, she earned a Bachelor of Science degree in Chemistry from the University of Virginia, completing her studies from 2001 to 2005. Her educational background provides a strong foundation for her expertise in the life sciences sector, particularly in addressing challenges related to drug development and commercialization.
Therapeutic Area Expertise
Brenda Goguen possesses broad therapeutic area expertise, particularly in rare diseases, neurology, and metabolic disorders. Her extensive experience in the life sciences sector enables her to navigate the complexities of product planning and strategy across various therapeutic areas. This knowledge is instrumental in her current role at Wave Life Sciences, where she contributes to the development of innovative solutions for unmet medical needs.